🦠 Melanoma - Feb 2026
• Personalized mRNA vaccine shows durable reduction in melanoma recurrence
• HOXD13 regulates angiogenesis and immune evasion in melanoma
• Pepyrus boosts sensitivity in HLA-bound neoantigen discovery
• SITC defines consensus criteria for ICI resistance
• Vibostolimab adds no benefit over pembrolizumab alone in melanoma
• Pathologic response assessment shows high reproducibility across tumor types
First Lady Melania Trump is leading the United Nations Security Council next week, and it's prompting some to wonder what the angle is for the Trumps to benefit. Writing for The Guardian on Saturday, columnist Arwa Mahdawi explained, "It is my working hypothesis that there are only two reasons a Tru...
🎗️ Melanoma — Recent Research
• Long-term survival improves with neoadjuvant checkpoint blockade
• Targeted therapy benefits linked to mutation burden
• CRISPR screens and toxicity insights refine immunotherapy strategy
Learn what your diagnosis means, explore current treatment options—including therapies that work with your immune system—and feel more confident as you move forward.
Stefano
br00t4c
Summarized Science
bk
cancergrace
Scientific Frontline
John Yates